The one comprehensive book on the topic; a useful resource for oncology residents or specialists interested in understanding cancer drug development.
"synopsis" may belong to another edition of this title.
EAE: Head, Department of Oncology, Queen's University, Medical Director, Oncology Program, Kingston General Hospital, Cancer Centre of Southeastern Ontario, Kingston, Canada; CT: Professor of Clinical Pharmacology and Oncology, Head, Section of Clinical Cancer Research Groups, Leeds Institute of Cancer Studies and Pathology, St. James's Institute of Oncology Leeds, UK; MB: Founder and Chairman, International Drug Development Institute, Louvain-la-Neuve, Belgium, Associate Professor of Biostatistics, Universiteit Hasselt Diepenbeek, Belgium
"About this title" may belong to another edition of this title.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition. Seller Inventory # 22159024
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In. Seller Inventory # ria9780199359011_new
Quantity: Over 20 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New. Seller Inventory # 22159024-n
Quantity: Over 20 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 22159024-n
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition. Seller Inventory # 22159024
Quantity: Over 20 available
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. Phase I trials are a critical first step in the study of novel cancer therapeutic approaches. As this title is the only comprehensive book on this topic, it is a useful resource for oncology trainees or specialists interested in understanding cancer drug development. Editor(s): Eisenhauer, Elizabeth A.; Twelves, Christopher; Buyse, Marc. Num Pages: 368 pages, With 24 illustrations. BIC Classification: MJCL; MJF; MMG. Category: (G) General (US: Trade). Dimension: 234 x 156 x 16. Weight in Grams: 522. . 2015. Second. paperback. . . . . Seller Inventory # V9780199359011
Quantity: Over 20 available
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Paperback / softback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Seller Inventory # C9780199359011
Quantity: Over 20 available
Seller: LiLi - La Liberté des Livres, CANEJAN, France
Condition: fine. edition 2015. l'article peut presenter de tres legers signes d'usure. vendeur professionnel; envoi soigne en 24/48h. Seller Inventory # 2411180004999
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. Phase I trials are a critical first step in the study of novel cancer therapeutic approaches. Their primary goals are to identify the recommended dose, schedule and pharmacologic behavior of new agents or new combinations of agents and to describe the adverse effects of treatment. In cancer therapeutics, such studies have particular challenges. Due to the nature of the effects of treatment, most such studies are conducted in patients with advanced malignancy, ratherthan in healthy volunteers. Further, the endpoints of these trials are usually measures adverse effects rather than molecular target or anti-tumor effects. These factors render the design, conduct,analysis and ethical aspects of phase I cancer trials unique. As the only comprehensive book on this topic, Phase I Cancer Clinical Trials is a useful resource for oncology trainees or specialists interested in understanding cancer drug development. New to this edition are chapters on Phase 0 Trials and Immunotherapeutics, and updated information on the process, pitfalls, and logistics of Phase I Trials Phase I trials are a critical first step in the study of novel cancer therapeutic approaches. As this title is the only comprehensive book on this topic, it is a useful resource for oncology trainees or specialists interested in understanding cancer drug development. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9780199359011
Quantity: 1 available
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. Phase I trials are a critical first step in the study of novel cancer therapeutic approaches. As this title is the only comprehensive book on this topic, it is a useful resource for oncology trainees or specialists interested in understanding cancer drug development. Editor(s): Eisenhauer, Elizabeth A.; Twelves, Christopher; Buyse, Marc. Num Pages: 368 pages, With 24 illustrations. BIC Classification: MJCL; MJF; MMG. Category: (G) General (US: Trade). Dimension: 234 x 156 x 16. Weight in Grams: 522. . 2015. Second. paperback. . . . . Books ship from the US and Ireland. Seller Inventory # V9780199359011